SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins steep selloff is driving attention, with traders pointing to leveraged long liquidations and broader risk-off pressure. The community is split between buying an oversold dip near technical support and expecting further declines if selling continues.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Phase 3 REGAL trial of GPS has reached the 80th event, and the company expects topline results this month, driving intense attention ahead of the AML data readout. Traders celebrated a sharp after-hours move and speculated about a data leak or short covering, while others cautioned that the trial remains blinded and its outcome is unknown.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs decision to remove Strategy from its indexes is fueling concerns about passive fund selling, while Bitcoins decline adds pressure to the stock. Traders debate whether the potential outflows are already priced in and whether the exclusion will materially weaken Strategys Bitcoin-linked financing model.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting complaints from users whose work was interrupted. Traders debated whether the prolonged disruption should pressure the stock, which held near flat-to-positive, while some speculated about a cyberattack without confirmation.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.03439229 USD and is down -2.16 over the last 24 hours. It is currently trading on 1895 active market(s) with $1,786,076,895.36 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is sliding alongside a broader crypto selloff, with traders pointing to risk-off sentiment, inflation and rate-hike concerns, and leveraged liquidations. The steep decline has sparked debate over whether support will hold or losses will deepen, while some holders are buying the dip and others cite stalled regulatory progress and weak demand as reasons for caution.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and Colette Kresss interim appointment have rattled NVDA shares, with traders also debating potential China chip-export scrutiny and the companys reliance on Huangs leadership. The community is split between buying the selloff on confidence in Nvidias AI business and avoiding the stock amid leadership and regulatory uncertainty.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,962,604.07029401. The last known price of Zcash is 956.58767703 USD and is down -2.92 over the last 24 hours. It is currently trading on 670 active market(s) with $828,877,374.43 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp pullback after a major rally is dominating discussion, with traders debating whether it is a broader crypto-market correction and liquidation flush or a deeper breakdown. Some call the selloff an oversold buying opportunity, while bears point to lost support and continued selling.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff and criticism of managements communication and credibility. Some traders see the delay as a manufacturing and regulatory hurdle rather than a problem with the clinical data, while others remain concerned about execution and the longer wait.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure alongside Bitcoins slide and broader weakness in crypto-linked stocks, with traders highlighting fresh lows and arguing over whether the selloff has further to run or the shares are forming a base. Some also point to COINs underperformance versus Bitcoin and concerns about trading activity, while a smaller group sees an oversold bounce opportunity.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNR is drawing attention amid weakness in Ethereum and broader crypto-linked stocks, with traders focused on its ETH-treasury exposure and the shares decline. The community is split between dip-buyers expecting a recovery and critics questioning Tom Lees strategy, company spending, transparency and buybacks.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pharma feels supply pain despite duty relief

New Delhi: Maintaining a steady supply of essential petrochemical inputs amid the West Asia conflict remains a concern for India's pharmaceutical industry, even though the government has waived customs duties on several of these products until June 30, according to industry executives.They said that while the duty waiver provides some cost relief to the sector, the main challenge is securing supplies and ensuring their timely movement."The government's decision to waive duties on select petrochemical products demonstrates its commitment to standing by the pharma industry but the far bigger challenge lies in ensuring the supply and timely movement of these materials," said Mehul Shah, a pharma industry expert.Shah pointed out that Saudi chemical giant SABIC declaring force majeure on methanol and styrene validates the industry's supply concerns.The disruption to shipping at the Strait of Hormuz has hit production of chemicals globally, especially in West Asia and Asia.The government on Thursday announced a temporary waiver on customs duty on over 40 critical petrochemical products, including anhydrous ammonia, methanol, styrene and polymers like PVC and PET chips.Namit Joshi, chairman of Pharmaceuticals Export Promotion Council of India (Pharmexcil), said it the duty waiver will be helpful only if the exporting nations maintain their invoicing price. "Unfortunately, that is beyond our control.

Why Did Poly Medicure Shares Crash 44% Despite Strong Long Term Growth?

Synopsis: Poly Medicure, with a market cap of ₹16,077 cr and 14 global manufacturing facilities, saw its stock fall ~44% due to moderated revenue growth of 5–6% in H1FY26. Strategic acquisitions and India–EU trade deal opportunities position it for 15–16% full-year growth. Poly Medicure, a key player in India’s medical devices sector, has recently faced significant […] The post Why Did Poly Medicure Shares Crash 44% Despite Strong Long Term Growth? appeared first on Trade Brains .

Buyer Not A Consumer If Purchase Made For Profit: SC

File Photo Of Supreme Court Of India New Delhi- In a significant verdict, the Supreme Court on Thursday held that if any purchase of goods or services is for profit generation, then the purchaser cannot be held to be a consumer and consequently cannot pursue cases under the Consumer Protection Act. A bench of Justices JB Pardiwala and Manoj Misra, delivering the judgement in an appeal filed by M/s Poly Medicure Ltd, affirmed the findings of the State and National Consumer Disputes Redressal Commissions that the complaint filed by the company was not maintainable under the Act. It held that a company purchasing software to automate its business processes cannot be regarded as a “consumer” under the Consumer Protection Act, 1986, as such a transaction is for a “commercial purpose”. Authoring the verdict, Justice Manoj Misra referred to various judgements and said, “the transaction of purchase of goods/ services (i.e., software) had a nexus with generation of profits and, therefore, qua that transaction the appellant cannot be considered a consumer as defined in Section 2(1)(d) of the 1986 Act.” If the transaction has a nexus with generation of profits, it would be treated as one for a commercial purpose, it said while dismissing the appeal of the firm.

Stocks to buy: Nagaraj Shetti recommends Poly Medicure, Oil India shares to buy

India's stock market remained stable after four days of losses, with Nifty 50 down 0.29% and BSE Sensex down 0.33%. Investor confidence was affected by U.S. visa fee hikes, foreign selling, and tariffs. Experts suggest cautious optimism for recovery in the IT sector and private banks.

Poly Medicure Acquires Italian Orthopaedics Firm For ₹324 Crore

Equity

Poly Medicure’s shares closed 1.5% higher at ₹1,982 on Wednesday

Trading Radar For September 24: Swiggy, Akzo Nobel, Dilip Buildcon, Lemon Tree, Torrent Stocks Are On Investors’ Watchlist

Benchmark indices are set for a weak opening, tracking cues from Asian markets.

Top Breakout Stock Ideas: Analysts Pick Biocon, KFin Tech, Poly Medicure, Sammaan Capital And More

Stocks such as Elgi Equipment, Supriya Life and Bajaj Consumer are on the breakout radar with upside potential, say analysts. 


Healthcare Stocks Get A GST Boost: Index Nears Breakout; Bull Run Likely In Apollo, Fortis, Dr Lal, Poly Medicure 

The analyst said the GST cut expands access to care while opening steady opportunities for companies in the sector.

Trading Radar For August 21: Vedanta, Zee Entertainment, Clean Science, India Cements, Railtel Are On Stocks Watchlist

Gem Aromatics, Patel Retail, Shreeji Shipping Global, Vikram Solar, and Mangal Electrical Industries IPOs are currently open for subscription

Solo-Dex And Polymedicure Partner To Bring Opioid-Free Acute Pain Management To India And Major Asian Markets

(MENAFN - ACCESSWIRE) NEW DELHI, INDIA AND WOLF CREEK, MT / ACCESS Newswire / August 6, 2025 / Solo-Dex, Inc., a U.S.-based medical device innovator, and Poly Medicure Ltd. (Polymed), India's ...

Poly Medicure Ltd. engages in the manufacture and sales of medical devices. Its products are used in infusion therapy, central venous access catheters, blood management, urology, dialysis, diagnostics, and pediatrics. The company was founded by Jugal Kishore Baid on March 30, 1995, and is headquartered in New Delhi, India.

Poly Medicure Ltd.

Neutral Sentiment

Poly Medicure has signed an agreement to acquire Medistream SA, which includes Citieffe SRL and its subsidiaries in the USA and Mexico, for an enterprise value of ₹324 crore (€31 million).The <a href="https://stocktwits.com/symbol/POLYMED.NSE">company’s stock</a> closed 1.5% higher at ₹1,982 on Wednesday.Citieffe specializes in orthopaedic trauma and extremities products, with direct operations in Italy, the USA, and Mexico, and distribution across more than 25 countries.Acquisition RationaleThe acquisition enables Poly Medicure to access the global orthopaedics market, particularly the trauma and extremities segment. Citieffe brings a differentiated, fully accredited, and patented portfolio of 45 trauma and extremity products with EU MDR and FDA clearances. The company holds over 12% market share in Italy and Mexico and has a growing presence in the U.S., the world’s largest orthopaedic market.The integrated business model of Citieffe, including R&amp;D, manufacturing, and sales, enables swifter product development and market introduction. Poly Medicure expects to leverage its manufacturing expertise and global distribution network to expand Citieffe’s presence, introduce its products in India, and potentially outsource certain manufacturing processes to India to improve margins.Poly Medicure will make an upfront payout of around €23 million, including repayment of shareholder loan liabilities. Existing management, including CEO Pascal Govi, will continue in their roles post-transaction. The deal is to close within four to eight weeks.On Tuesday, Poly Medicure’s Dutch unit RisoR Holdings completed the acquisition of Pendracare Holdings B.V. and Welling Medical B.V.Stock WatchRetail sentiment on Stocktwits turned ‘bullish’ from ‘neutral’ a day earlier.<figure class="image"><img style="aspect-ratio:919/94;" src="https://news.stocktwits-cdn.com/Poly_Medicure_png_39f9f07277.webp" alt="Poly Medicure.png" width="919" height="94"><figcaption>Poly Medicure's Sentiment Meter and Message Volumes on September 24 | Source: Stocktwits</figcaption></figure>However, the stock has been under selling pressure this year, declining nearly 25%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Mergers and Acquisitions message in neon lights. (Image Courtesy: Getty Images)

Current Price	1,680.70
Prev Close	1,694.70
Open	1,682.00
Dividend Yield	0.29%
50-Day Moving Average	1,620.78
Beta	N/A
Avg. Volume	77,029.68
PE Ratio	53.90

52-Week High	2,024.00
52-Week Low	1,182.00
Market Capitalization	169.67B
EPS (Annual)	31.79
Price to Book	5.26
Revenue Per Employee	7.12M

Feed

News

Sentiment

Fundamentals

Info

POLYMED.NSE Fundamentals